Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,674
archived clinical trials in
Skin Cancer

Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Sanford Broadway Clinic
mi
from
Fargo, ND
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Sanford Broadway Clinic
mi
from
Fargo, ND
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
mi
from
Allentown, PA
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
mi
from
Allentown, PA
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
AnMed Cancer Center
mi
from
Anderson, SC
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
AnMed Cancer Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Sioux Valley Hospital at University of South Dakota Medical Center
mi
from
Sioux Falls, SD
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Sioux Valley Hospital at University of South Dakota Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Green Bay Oncology, Limited at St. Vincent Hospital
mi
from
Green Bay, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Green Bay Oncology, Limited at St. Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Franciscan Skemp Healthcare - La Crosse Campus
mi
from
La Crosse, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Franciscan Skemp Healthcare - La Crosse Campus
mi
from
La Crosse, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Bay Area Cancer Care Center at Bay Area Medical Center
mi
from
Marinette, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Bay Area Cancer Care Center at Bay Area Medical Center
mi
from
Marinette, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Aurora Presbyterian Hospital
mi
from
Aurora, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Aurora Presbyterian Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Boulder Community Hospital
mi
from
Boulder, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Boulder Community Hospital
mi
from
Boulder, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Penrose Cancer Center at Penrose Hospital
mi
from
Colorado Springs, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Penrose Cancer Center at Penrose Hospital
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Anthony Central Hospital
mi
from
Denver, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Anthony Central Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Porter Adventist Hospital
mi
from
Denver, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Porter Adventist Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Joseph Hospital
mi
from
Denver, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Joseph Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Rose Medical Center
mi
from
Denver, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Rose Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Colorado Cancer Research Program, Inc.
mi
from
Denver, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Colorado Cancer Research Program, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Swedish Medical Center
mi
from
Englewood, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Swedish Medical Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Front Range Cancer Specialists
mi
from
Fort Collins, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Front Range Cancer Specialists
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
mi
from
Grand Junction, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
mi
from
Grand Junction, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
North Colorado Medical Center
mi
from
Greeley, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
North Colorado Medical Center
mi
from
Greeley, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Sky Ridge Medical Center
mi
from
Lone Tree, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Sky Ridge Medical Center
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Hope Cancer Care Center at Longmont United Hospital
mi
from
Longmont, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Hope Cancer Care Center at Longmont United Hospital
mi
from
Longmont, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
McKee Medical Center
mi
from
Loveland, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
McKee Medical Center
mi
from
Loveland, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Mary - Corwin Regional Medical Center
mi
from
Pueblo, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Mary - Corwin Regional Medical Center
mi
from
Pueblo, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
North Suburban Medical Center
mi
from
Thornton, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
North Suburban Medical Center
mi
from
Thornton, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Graham Hospital
mi
from
Canton, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Graham Hospital
mi
from
Canton, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Memorial Hospital
mi
from
Carthage, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Memorial Hospital
mi
from
Carthage, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Eureka Community Hospital
mi
from
Eureka, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Eureka Community Hospital
mi
from
Eureka, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Galesburg Clinic, PC
mi
from
Galesburg, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Galesburg Clinic, PC
mi
from
Galesburg, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Galesburg Cottage Hospital
mi
from
Galesburg, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Galesburg Cottage Hospital
mi
from
Galesburg, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Mason District Hospital
mi
from
Havana, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Mason District Hospital
mi
from
Havana, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Hopedale Medical Complex
mi
from
Hopedale, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Hopedale Medical Complex
mi
from
Hopedale, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Joliet Oncology-Hematology Associates, Limited - West
mi
from
Joliet, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Joliet Oncology-Hematology Associates, Limited - West
mi
from
Joliet, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
McDonough District Hospital
mi
from
Macomb, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
McDonough District Hospital
mi
from
Macomb, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
BroMenn Regional Medical Center
mi
from
Normal, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
BroMenn Regional Medical Center
mi
from
Normal, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Community Cancer Center
mi
from
Normal, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Community Cancer Center
mi
from
Normal, IL
Click here to add this to my saved trials